Translate this page into:
Smokeless tobacco dependence managed by Phosphorous in LM potency - A case report
*Corresponding author: Dr. Sreeja Kudukayil Radhakrishnan Nair, Department of Psychiatry, National Homoeopathy Research Institute in Mental Health, Kottayam, Kerala, India. drsreejasankar@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Kudukayil Radhakrishnan Nair S, Kalaripparambil Ummar N. Smokeless tobacco dependence managed by Phosphorous in LM potency - A case report. J Integr Stand Homoeopath. 2025;8:153-8. doi: 10.25259/JISH_75_2024
Abstract
The use of smokeless tobacco (SLT)products is common in India and is associated with several health hazards. Non nicotine replacement therapies are widely accepted by the Food and Drug Administration in India to enable cessation of tobacco smoking. However, their risks limit their use. Thus appropriate treatment method with minimal to no side effects for the cessation of tobacco is a necessity. A 25 year old man with a dependence on Hans (chapped tobacco) was treated with the homoeopathic remedy Phosphorus in LM (50 millessimal) potency. His Fagerstrom test for nicotine dependence SLT score was initially 6, it went down to 3 after 4 months of treatment and 0 after 7 months of treatment. The patient has been stable for 18 months. In this case, individualized homoeopathic treatment has shown a positive role in the significant reduction in SLT dependence without causing any adverse events. Further studies are required in this area.
Keywords
Fagerstrom test for nicotine dependence-smokeless tobacco
Homoeopathic medicine
LM potency
Phosphorus
Smokeless tobacco
INTRODUCTION
Tobacco dependence is defined by the national tobacco control programme, India, as a ‘cluster of behavioural, cognitive and physiological phenomena that develop after repeated tobacco use and include a strong desire to use tobacco, difficulties in controlling its use and persistence in its use despite its harmful consequences’.[1] The international classification of diseases (ICD) 11 defines nicotine dependence as a disorder of regulation of nicotine use arising from repeated or continuous use of nicotine. The characteristic feature is a strong internal drive to use nicotine, which is manifested by the impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use nicotine. The physiological features of dependence may also be present, including tolerance to the effects of nicotine, withdrawal symptoms following cessation or reduction in use of nicotine, or repeated use of nicotine or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months.[2]
Various forms of smokeless tobacco (SLT) consumed in India include betel quid chewing, mishri, khaini, gutka, snuff, tambakoo, mawa, chap and as an ingredient in pan masala.[3-5] Several SLT products, such as madhu chhap, hans chhap, miraj and gutkha, are commonly available in the Indian market.[6,7] Approximately 29.6% of men, 12.8% of women and 21.4% of the entire adult population use SLT in India currently. Among regular users, the average age at initiation is 18.8 years.[8] The disease burden of SLT is approximately 4.38 million annual national disability-adjusted life years, 4.3 million years of life lost and over 171 thousand deaths due to oral and stomach cancer and ischemic heart disease.[9]
Chewing tobacco and snuff are similar SLT products that are stored in the mouth and spit out after use.[10] Absorption takes place through the buccal mucosa.[11] Typically, a dose of SLT comprises 3.6–4.5 mg of nicotine. The brain starts to respond to this nicotine content within 30 min of intake; the effect lasts for up to 60 min after use.[10]
The use of chewing tobacco is associated with numerous dental, periodontal, and oral soft-tissue problems, including loss of periodontal attachment, tooth staining, halitosis, and leukoplakia.[10] SLT is composed of more than 30 carcinogens, including nitrosamines, nitrates, and nitrites, as well as heavy metals.[12,13] More than 90% of the carcinoma of the oral cavity is due to tobacco use.[14]
The Fagerstrom test for nicotine dependence-smokeless tobacco (FTND-ST) is a standard scale used for assessing the intensity of SLT addiction.[15]
More than half of Indian tobacco users wish to quit, but the addictive nature of tobacco poses a challenge to this.[14] First-line drugs such as bupropion and varenicline are the non-nicotine replacement therapy approved for the cessation of tobacco use by the Food and Drug Administration in India. However, both these drugs are known to produce adverse events, including psychological problems.[5,16] This throws light on the necessity of an appropriate pharmacological aid with minimal to no side effects for the cessation of tobacco.
Several alternative therapies are included, such as acupuncture, pranayama-like breathing exercises, yoga, meditation, and the use of traditional products like Avena sativa, calamus, herbal tea, and black pepper.[14] The most effective and recognised way of stopping tobacco use is by incorporating both behavioural and pharmacological interventions.[17] Homoeopathic medicines such as Arsenicum album, Nux vomica, Plantago, Calcarea phosphorica, Camphora, Cinchona, Coca, Kola, Olibanum sacrum, Phosphorus, Spigelia, Staphysagria, Tabacum, and Tamarind are mentioned in the literature for their usefulness in reducing the craving for tobacco.[18] A study by Deepak shows sulphur as the most frequently indicated remedy for tobacco dependence. Nux vom, Calc carb, Ars alb, Nat mur, Staph, Ignatia, Caladium and Phosphorus were the other indicated remedies.[19] The available literature in homoeopathy for tobacco dependence focuses on tobacco smoking.[5,14,20] Studies related to the use of homoeopathic medicines for SLT dependence are scarce. We present a case report wherein homoeopathic treatment helped wean a patient off the use of SLT.
CASE REPORT
Presenting complaint
A 25-year-old man presented to the outpatient department of the National Homoeopathy Research Institute in Mental Health, Kottayam, on February 28, 2023, with complaints of craving for Hans (a chap form of tobacco), which he uses 4–5 times daily, approximately 3–4 packets (15 g/packet) a day for the past 8 years. The craving was so severe; it interfered with his physical, mental, and social functioning and resulted in a breakup of his relationship. It caused the patient to be in a state of depression; he was treated with the allopathic medications mirtazapine 7.5 mg and lithium carbonate 300 mg for 4 years; the medications were stopped 4 months prior.
History of presenting complaint
The patient was apparently well up to the age of 17 years. Around that time, he started using Hans, cannabis and alcohol due to peer pressure. Initially, he used to take Hans every 1 h. He stopped cannabis and alcohol intake by himself approximately 3 years prior, but was unable to stop Hans due to the strong craving.
Family history
The patient’s father has a history of cerebrovascular accident, and the patient’s mother has hypothyroidism and rheumatoid arthritis.
Life space investigation
The patient is from a middle-class family. He is the elder child and has a younger sister. He was studying for a BSc in physics, but was unable to complete it. He had been working in the sales section at a bank for 10 months, but stopped due to COVID-19. He had a relationship, but that broke up due to his tobacco addiction; the breakup triggered his depression.
Physical generals
The patient has reduced appetite and increased thirst for cold drinks. He has perspiration all over. The patient’s thermal sensitivity is towards the chilly side.
Constitutional features
The patient is thin and lean, with a fair complexion.
Mental generals
He is sociable and easily interacts with and makes company of others, has political interests, loves reading, and has a desire to travel.
Mental status examination
General appearance and behaviour: Conscious, aware of his surroundings, well kempt, and rapport established easily
Eye to eye contact: Maintained
Interpersonal relationship: Good
Psychomotor activity: Normal
Speech: Rate of speech: Normal
Affect: Appropriate
Mood: Subjective: No predominant mood
Objective: Euthymic
Thoughts: Flow: Nothing abnormally detected (NAD), Form: NAD, Content: Preoccupied thoughts of SLT use
Perceptual disorder: Hallucinations: Nil, Illusions: Nil
Orientation to: Time – Good, Place – Good, Person – Good
Memory: Good
General Information and Intelligence: Good
Attention and concentration: Good
Abstract thinking: Good
Judgement: Social judgement: Good, Test judgement: Good, Insight: Intellectual insight
General physical examination
Vitals were stable.
Systemic examination
Nothing abnormally detected.
Diagnostic assessment
As the patient showed a strong drive to use SLT, which he himself could not control, and priority given to the use of substance, which even affected his personal life in the form of a breakup and a duration of 8 years of usage, the case was diagnosed as Nicotine dependence (6C4A.2) as per ICD-11. The FTND-ST score was 6, suggesting significant dependence.
Therapeutic intervention
Phosphorus was chosen as the individualised homoeopathic medicine based upon the totality of the patient including the lean body with fair complexion, friendly behaviour, cold cravings and tobacco desire. The repertorisation chart is provided in Figure 1.

- Repertorisation chart.
Posology selection based on parameters
The patient had a strong craving to use the substance daily, with a long duration of onset and frequent use of addictive substances. All these indicated a lower susceptibility, which is why the LM (50 millessimal) potency was selected; the use of the LM potency enables frequent repetition. The initial prescription was the 0/1 potency in 100 ml of aqua with 10 succussions. The patient was asked to perform the succussion process 10 times before taking the medicine. He was advised to take 1 spoon twice a day in ½ glass of aqua. The dose was repeated and the potency modified according to the change in symptomatology.
Follow-up and outcomes
Follow-up and interventions are shown in Table 1. Change in scale score is shown in Figure 2. The Modified Naranjo criteria for this case are provided in Table 2. No adverse reactions were reported in this case.
| Month | Observation | FTND-ST score | Intervention |
|---|---|---|---|
| February 2023 (Baseline) | 3–4 packets (15 g/packet) of chapped tobacco (Hans) daily | 6 | Phos 0/1 aqua -1 spoon BD in half cup |
| March 2023 | Daytime usage of Hans has reduced. Taking 2–3 packets in the afternoon. Appetite increased | 5 | Phos 0/1 aqua 1 spoon BD in half cup Advised to take pepper powder immediately after use of Hans Suggested to watch the adverse effect of tobacco videos and images. |
| April 2023 | Hans usage reduced (2 packets/day) appetite reduced Mentally, he is calm now |
4 | Phosphorus 0/1 in aqua 1 spoon BD (continuing pepper powder) |
| May 2023 | Mentally calm. Tried to abstain from Hans for 24 h, but next day frequency increased (1–2 packets times a day). Again, tried for 24 h and frequency increased again | 5 | Phosphorus 0/2 in aqua 1 spoon BD (continuing pepper powder) |
| June 2023 | Hans’ usage increased (2 packets, 3–4 times a day) due to stress about his girlfriend and family land dispute. Sleeplessness |
5 | Phosphorus 0/3 in aqua 1 spoon BD (continuing pepper powder) |
| July 2023 | Better than before Reduced Hans’ usage to 1 pack in 2 days. Now using pepper mixed with Hans Sleep is good |
3 | Phosphorus 0/3 in aqua 1 spoon BD |
| August 2023 | Decreased usage (1 pack in 2–3 days) trying black pepper mixed in Hans | 3 | Phosphorus 0/3 in aqua 1 spoon BD |
| September 2023 | Decreased Hans’ usage (1 pack in 2–3 days with decreased frequency). Presented with abdominal pain, vomiting and abdominal discomfort due to outside food | 3 | Phosphorus 0/3 in aqua 1 spoon BD Ars alb 1M 3 doses (1 dose+2 doses SOS) |
| October 2023 | Hans’ usage reduced (1 pack per week) | 1 | Phosphorus 0/3 in aqua 1 spoon BD |
| November 2023 | Hans’ usage reduced Sleep disturbed Fluent watery coryza |
0 | Phosphorus 0/3 in aqua 1 spoon BD Allium cepa 30 in pills TDS |
| December 2023 | Status quo | 0 | Phosphorus 0/3 in aqua 1 spoon BD |
| January 2024 | Usage increased for 3 days in between during Stress related to the job Mentally down. Once while checking at forest, he got caught by police in front of his friends and felt ashamed about it. |
1 | Phosphorus 0/4 in aqua 1 spoon BD |
| February 2024 (1 year) | 1 pack in a week One full day without Hans, only with pepper. General improvement |
0 | Phosphorus 0/4 in aqua 1 spoon BD |
| March 2024 | Consumed Hans only during examination that too mixed with pepper. Not using otherwise | 0 | Phosphorus 0/4 in aqua 1 spoon BD |
| April 2024 | Stress over his girlfriend Continuing his course but cannot focus on studies Now using only pepper in the Hans packet |
0 | Phosphorus 0/4 in aqua 1 spoon BD |
| May 2024 | Concentration in studies improving Fully stopped using Hans for 1 week. |
0 | Phosphorus 0/4 in aqua 1 spoon BD |
| June 2024 | Father was hospitalised with myocardial infarction. Patient was severely stressed, but managed without taking Hans. | 0 | Phosphorus 0/4 in aqua 1 spoon BD |
| July 2024 | Father discharged under semi-ventilator at home, stress persisting, wants to use Hans, but has avoided so far | 0 | Phosphorus 0/4 in aqua 1 spoon BD |
| August 2024 (1 year, 6 months) |
No use of Hans | 0 | Phosphorus 0/4 in aqua 1 spoon BD |
FTND-ST: Fagerstrom test for nicotine dependence-smokeless tobacco, BD: Bis in die (twice a day), SOS: Si opus sit (as required), TDS: Ter die sumendum (thrice a day)
| Criteria | Yes | No | Not sure or N/A | Score for this case |
|---|---|---|---|---|
| 1. Was there an improvement in the main symptom or condition for which the homeopathic medicine was prescribed? | +2 | −1 | 0 | +2 |
| 2. Did the clinical improvement occur within a plausible timeframe relative to the drug intake? | +1 | −2 | 0 | +1 |
| 3. Was there a homeopathic aggravation of symptoms? | +1 | 0 | 0 | 0 |
| 4. Did the effect encompass more than the main symptom or condition (i.e., were other symptoms, not related to the main presenting complaint, improved or changed)? | +1 | 0 | 0 | +1 |
| 5. Did overall well-being improve? (Suggest using a validated scale or mention changes in physical, emotional and behavioural elements) | +1 | 0 | 0 | +1 |
| 6 (A) Direction of cure: Did some symptoms improve in the opposite order of the development of symptoms of the disease? | +1 | 0 | 0 | 0 |
| 6 (B) Direction of cure: Did at least one of the following aspects apply to the order of improvement of symptoms: • From organs of more importance to those of less importance • From deeper to more superficial aspects of the individual • From the top downwards |
+1 | 0 | 0 | 0 |
| 7. Did ‘old symptoms’ (defined as non-seasonal and non-cyclical symptoms that were previously thought to have resolved) reappear temporarily during the course of improvement? | +1 | 0 | 0 | 0 |
| 8. Are there alternative causes (other than the medicine) that – with a high probability – could have produced the improvement? (Consider known course of disease, other forms of treatment and other clinically relevant interventions) | −3 | +1 | 0 | 0 |
| 9. Was the health improvement confirmed by any objective evidence*? (e.g., investigations, clinical examination, etc.) | +2 | 0 | 0 | +2 |
| 10. Did repeat dosing, if conducted, create similar clinical improvement? | +1 | 0 | 0 | +1 |
| Total score (range−3–13), N/A: Not applicable | 8 | |||

- Change in Fagerstrom test for nicotine dependence-smokeless tobacco (FTND-ST) score during follow-ups.
DISCUSSION
Nicotine addiction, in all its forms, is a significant and increasing public health hazard. De-addiction is made difficult by the presence of neuronal nicotinic acetylcholine receptors, which regulate both the rewarding and aversive effects of nicotine.[11,21]
Literature suggests the role of herbal products like black pepper and lime in reducing the craving for tobacco smoking.[22] In this case, the patient was asked to mix pepper powder with the SLT product to reduce the reward and to create aversion as a method to reduce the SLT dependence.
The current case demonstrates the benefits of the homoeopathic remedy Phosphorus in SLT dependence. The frequent repetition, minimal aggravation and the use of minimal material doses associated with LM potencies contributed to a unique therapeutic profile that enables quicker recovery.[23] The LM potency was used in this case to allow frequent repetition; this was to combat the patient’s frequent cravings for SLT. The use of LM potency was found to be safe as well.
In dependent users, SLT abstinence is typically accompanied by an urge to consume the same, restlessness, hunger, irritability and other adverse mood changes.[24,25] Other less frequent but occasionally severe tobacco withdrawal symptoms include insomnia, mouth ulcers and constipation.[26-28] None of these symptoms occurred in the present case; this raises the possibility that using homoeopathic treatment, especially in the LM potency, could help prevent withdrawal symptoms.
CONCLUSION
The current case highlights the effectiveness of the indicated individualised homoeopathic medicine Phosphorus in LM potency, based on susceptibility, in the treatment of SLT dependence, and suggests future research in this area. Controlled studies are necessary to explore the effectiveness and efficacy of homeopathic medicines in this most-needed area.
Ethical considerations
Consent was obtained for clinical information to be reported in the journal. The patient understands that their name and initials will not be published, and every effort will be made to conceal their identity.
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- National tobacco control programme India: Tobacco Dependence Treatment Guidelines; 2011.
- [Google Scholar]
- The ICD classification of mental and behavioural disorders (11th ed). Delhi: World Health Organization; 2018. p. :124.
- [Google Scholar]
- Available from: https://extranet.who.int/fctcapps/fctcapps/fctc/kh/slt/news/smokeless-tobacco-slt-products [Last accessed on 2024 Aug 29]
- Declining trend of smoking and smokeless tobacco in India: A decomposition analysis. PLoS One. 2021;16:e0247226.
- [CrossRef] [PubMed] [Google Scholar]
- Comparative efficacy of nonnicotine replacement therapy (homeopathy medicine) and placebo with behavioral counseling on tobacco abstinence among adult tobacco users in Pune: A randomized control trial. J Datta Meghe Inst Med Sci Univ. 2021;16:642-7.
- [CrossRef] [Google Scholar]
- Smokeless tobacco products profile and pictorial warning labels in India: A review. Popul Med. 2019;1:7.
- [CrossRef] [Google Scholar]
- Global adult tobacco survey 2016-2017 Maharashtra: International Institute for Population Sciences; 2017. p. :64.
- [Google Scholar]
- Prevalence of smokeless tobacco use in India and its association with various occupations: A LASI study. Front Public Health. 2023;11:1005103.
- [CrossRef] [PubMed] [Google Scholar]
- Death, disability, and premature life years lost due to cigarettes, bidis, and smokeless tobacco in India: A comparative assessment. Addict Health. 2023;15:53-62.
- [CrossRef] [PubMed] [Google Scholar]
- Kaplan and Sadock's comprehensive textbook of psychiatry (12th ed). Philadelphia, PA: Lippincott Williams & Wilkins; 2020. p. :1353-59.
- [Google Scholar]
- Role of homoeopathy in tobacco addiction-a narrative review. Int J Res Rev. 2020;7:296-310.
- [Google Scholar]
- Relationship between type of smokeless tobacco & risk of cancer: A systematic review. Indian J Med Res. 2018;148:56-76.
- [CrossRef] [PubMed] [Google Scholar]
- Associations between oral hygiene habits, diet, tobacco and alcohol and risk of oral cancer: A case-control study from India. Cancer Epidemiol. 2017;51:7-14.
- [CrossRef] [PubMed] [Google Scholar]
- A prospective observational study on the therapeutic effect of Plantago major in reducing craving for tobacco. Homœopath Links. 2019;32:145-51.
- [CrossRef] [Google Scholar]
- Psychometric properties of Fagerström test for nicotine dependence for smokeless tobacco users (FTND-ST) Nicotine Tob Res. 2017;19:1095-101.
- [CrossRef] [PubMed] [Google Scholar]
- Effects of interventions to combat tobacco addiction: Cochrane update of 2019 and 2020 reviews. Addiction. 2022;117:1573-88.
- [CrossRef] [PubMed] [Google Scholar]
- Complementary and alternative medicine/therapy for tobacco cessation in India: A secondary analysis of GATS-1 and 2. Indian J Community Med. 2024;49:144-51.
- [CrossRef] [PubMed] [Google Scholar]
- Synthesis repertorium homeopathicum syntheticum (Reprint ed). Uttar Pradesh: B. Jain Publishers Pvt. Limited; 2021.
- [Google Scholar]
- A clinical study on the effectiveness of individualized homoeopathic medicines in reducing the dependence in tobacco use disorder. Int J Homoeopath Sci. 2023;7:203-8.
- [CrossRef] [Google Scholar]
- The effectiveness of a homoeopathic complex (Caladium seguinum 30CH. Nux vomica 30CH and Staphysagria delphinium 30CH) compared to a tautopathic preparation of the cigarette smoked in the management of nicotine withdrawal syndrome. Diss.
- [Google Scholar]
- Neurobiological mechanisms of nicotine reward and aversion. Pharmacol Rev. 2022;74:271-310.
- [CrossRef] [PubMed] [Google Scholar]
- Role of herbal medication in tobacco cessation treatment: A systematic review and meta-analysis. Addict Health. 2023;15:63-70.
- [CrossRef] [PubMed] [Google Scholar]
- Homeopathic aggravation with Quinquaginta millesimal potencies. Homoeopathy. 2012;101:112-20.
- [CrossRef] [PubMed] [Google Scholar]
- Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine Tob Res. 2007;9:315-27.
- [CrossRef] [PubMed] [Google Scholar]
- Revision of the Wisconsin smoking withdrawal scale: Development of brief and long forms. Psychol Assess. 2021;33:255-66.
- [CrossRef] [PubMed] [Google Scholar]
- Sleep disturbance during smoking cessation: Withdrawal or side effect of treatment. J Smok Cessat. 2017;12:63-70.
- [CrossRef] [PubMed] [Google Scholar]
- The relationship between smoking cessation and mouth ulcers. Nicotine Tob Res. 2004;6:655-9.
- [CrossRef] [PubMed] [Google Scholar]
- Stopping smoking can cause constipation. Addiction. 2003;98:1563-7.
- [CrossRef] [PubMed] [Google Scholar]

